Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Tularaemia: bioterrorism defence renews interest in Francisella tularensis.

Oyston PC, Sjostedt A, Titball RW.

Nat Rev Microbiol. 2004 Dec;2(12):967-78. Review.

PMID:
15550942
2.

Francisella tularensis vaccines.

Griffin KF, Oyston PC, Titball RW.

FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. Epub 2007 Feb 22. Review.

3.

Vaccination strategies for Francisella tularensis.

Isherwood KE, Titball RW, Davies DH, Felgner PL, Morrow WJ.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1403-14. Review.

PMID:
15919131
4.

Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.

Sjöstedt A.

Ann N Y Acad Sci. 2007 Jun;1105:1-29. Epub 2007 Mar 29. Review.

PMID:
17395726
5.

A vaccine for tularaemia.

Titball RW, Oyston PC.

Expert Opin Biol Ther. 2003 Jul;3(4):645-53. Review.

PMID:
12831369
6.

Francisella tularensis: unravelling the secrets of an intracellular pathogen.

Oyston PC.

J Med Microbiol. 2008 Aug;57(Pt 8):921-30. doi: 10.1099/jmm.0.2008/000653-0. Review.

PMID:
18628490
7.

Vaccines against Francisella tularensis.

Wayne Conlan J, Oyston PC.

Ann N Y Acad Sci. 2007 Jun;1105:325-50. Epub 2007 Mar 29. Review.

PMID:
17395730
8.

Tularemia.

Nigrovic LE, Wingerter SL.

Infect Dis Clin North Am. 2008 Sep;22(3):489-504, ix. doi: 10.1016/j.idc.2008.03.004. Review.

PMID:
18755386
9.

Will the enigma of Francisella tularensis virulence soon be solved?

Titball RW, Johansson A, Forsman M.

Trends Microbiol. 2003 Mar;11(3):118-23. Review.

PMID:
12648943
10.

The unraveling panoply of Francisella tularensis virulence attributes.

Meibom KL, Charbit A.

Curr Opin Microbiol. 2010 Feb;13(1):11-7. doi: 10.1016/j.mib.2009.11.007. Epub 2009 Dec 23. Review.

PMID:
20034843
11.

Tularaemia: a challenging zoonosis.

Carvalho CL, Lopes de Carvalho I, Zé-Zé L, Núncio MS, Duarte EL.

Comp Immunol Microbiol Infect Dis. 2014 Mar;37(2):85-96. doi: 10.1016/j.cimid.2014.01.002. Epub 2014 Jan 13. Review.

PMID:
24480622
12.

Francisella tularensis vaccines.

Oyston PC.

Vaccine. 2009 Nov 5;27 Suppl 4:D48-51. doi: 10.1016/j.vaccine.2009.07.090. Review.

PMID:
19837286
13.

Vaccines against Francisella tularensis--past, present and future.

Conlan JW.

Expert Rev Vaccines. 2004 Jun;3(3):307-14. Review.

PMID:
15176947
14.

[Francisella tularensis--feature of pathogen, pathogenesis, diagnostics].

Osiak B, Bartoszcze M, Gawel J.

Przegl Epidemiol. 2006;60(3):601-8. Review. Polish.

PMID:
17249186
15.

Biosafety and selectable markers.

Titball RW, Sjostedt A, Pavelka MS Jr, Nano FE.

Ann N Y Acad Sci. 2007 Jun;1105:405-17. Epub 2007 Apr 7. Review.

PMID:
17416926
16.

Molecular and genetic basis of pathogenesis in Francisella tularensis.

Barker JR, Klose KE.

Ann N Y Acad Sci. 2007 Jun;1105:138-59. Epub 2007 Mar 29. Review.

PMID:
17395737
17.

Tularemia: the disease and the weapon.

Cronquist SD.

Dermatol Clin. 2004 Jul;22(3):313-20, vi-vii. Review.

PMID:
15207312
18.

The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.

Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB.

J Leukoc Biol. 2005 Jun;77(6):893-7. Epub 2005 Mar 9. Review.

PMID:
15758077
19.

Tularemia pneumonia.

Thomas LD, Schaffner W.

Infect Dis Clin North Am. 2010 Mar;24(1):43-55. doi: 10.1016/j.idc.2009.10.012. Review.

PMID:
20171544
20.

Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.

Greenfield RA, Bronze MS.

Drug Discov Today. 2003 Oct 1;8(19):881-8. Review.

PMID:
14554016

Supplemental Content

Support Center